学术探索
学术期刊
新闻热点
数据分析
智能评审

Trastuzumab in combination with chemotherapy for the treatment of metastatic breast cancer

被引：33
作者：
Fornier, M
Esteva, FJ
Seidman, AD
机构：
[1] Mem Sloan Kettering Canc Ctr, Breast Canc Med Serv, New York, NY 10021 USA
[2] Univ Texas, MD Anderson Canc Ctr, Dept Breast Med Oncol, Houston, TX 77030 USA
来源：
SEMINARS IN ONCOLOGY | 2000年 / 27卷 / 06期
关键词：
D O I：
10.1053/sonc.2000.19902
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：38 / 45
页数：8
相关论文
共 31 条
  • [1] COMPREHENSIVE CRITERIA FOR ASSESSING THERAPY-INDUCED TOXICITY
    AJANI, JA
    WELCH, SR
    RABER, MN
    FIELDS, WS
    KRAKOFF, IH
    [J]. CANCER INVESTIGATION, 1990, 8 (02) : 147 - 159
  • [2] [Anonymous], P AM SOC CLIN ONCOL
  • [3] BACUS SS, IN PRESS BREAST DIS
  • [4] THE NEU ONCOGENE ENCODES AN EPIDERMAL GROWTH-FACTOR RECEPTOR-RELATED PROTEIN
    BARGMANN, CI
    HUNG, MC
    WEINBERG, RA
    [J]. NATURE, 1986, 319 (6050) : 226 - 230
  • [5] Baselga J, 1997, Oncology (Williston Park), V11, P43
  • [6] Phase II study of weekly intravenous recombinant humanized Anti-p185(HER2) monoclonal antibody in patients with HER2/neu-overexpressing metastatic breast
    Baselga, J
    Tripathy, D
    Mendelsohn, J
    Baughman, S
    Benz, CC
    Dantis, L
    Sklarin, NT
    Seidman, AD
    Hudis, CA
    Moore, J
    Rosen, PP
    Twaddell, T
    Henderson, IC
    Norton, L
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1996, 14 (03) : 737 - 744
  • [7] Baselga J, 1998, CANCER RES, V58, P2825
  • [8] Phase II trial of docetaxel and Herceptin (R) as first- or second-line chemotherapy for women with metastatic breast cancer whose tumours overexpress HER2
    Burris, HA
    Hainesworth, JD
    Albain, K
    Huntington, M
    Greco, FA
    Erland, J
    Hussain, A
    Vogel, CL
    [J]. EUROPEAN JOURNAL OF CANCER, 1999, 35 : S322 - S322
  • [9] Multinational study of the efficacy and safety of humanized anti-HER2 monoclonal antibody in women who have HER2-overexpressing metastatic breast cancer that has progressed after chemotherapy for metastatic disease
    Cobleigh, MA
    Vogel, CL
    Tripathy, D
    Robert, NJ
    Scholl, S
    Fehrenbacher, L
    Wolter, JM
    Paton, V
    Shak, S
    Lieberman, G
    Slamon, DJ
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (09) : 2639 - 2648
  • [10] FORNIER M, 1999, P AN M AM SOC CLIN, V18, pA126
1234